Stock Apimeds Pharmaceuticals US Files for 3.33M Share IPO at $3-$4/sh by November 8, 2024 written by November 8, 2024 Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share. This post appeared first on investing.com 0 comment 0 FacebookTwitterPinterestEmail previous post Richemont shares fall amid sluggish China demand, margin pressures next post TSMC to suspend production of advanced AI chips for China from Monday, FT reports You may also like BASF results down on impairments, restructuring January 27, 2025 European chipmakers slump as traders gauge DeepSeek AI... January 27, 2025 Nasdaq futures tumble as China’s AI push rattles... January 27, 2025 China Vanke’s CEO, chairman resign amid growing liquidity... January 27, 2025 Fuji Media, rocked by sexual misconduct allegations, says... January 27, 2025 Italy’s MPS shares fall ahead of Mediobanca board... January 27, 2025 British Land stock drops following stake sale January 27, 2025 UMG shares rally after new multi-year pact with... January 27, 2025 BASF shares indicated 3% lower as impairments drag... January 27, 2025 Ryanair cuts 2026 traffic forecast amid ongoing Boeing... January 27, 2025